Microfluidic Platform CapitalBiotech

CapitalBiotech developed this platform for rapid, multi-target nucleic acid detection. When used with compatible detection kits, the platform supports applications in medical diagnostics, life sciences, food safety, agricultural testing, animal health, and aquaculture.

The platform integrates microfluidic technology with isothermal amplification to enable sample detection within 50 minutes. Fluorescence signals are transmitted to the computer and processed by the accompanying software to generate real-time amplification curves. Once detection is complete, results are automatically interpreted and displayed.